Clinical study to evaluate the safety and performance of the Axxent electronic brachytherapy system in women with resected, early stage breast cancer

The objectives of this study are:

• To evaluate the performance of the Xoft treatment system in patients with resected, early stage breast cancer
• To evaluate the safety of the Xoft treatment system in patients with resected, early stage breast cancer

You may be eligible to participate in this study if you:

• Are over 50 years of age
• Have a tumor with T1, NO, MO (AJC classification)
• Have invasive ductal carcinoma or ductal carcinoma in situ
• Have negative microscopic surgical margins of at least 1mm in all directions
• Have adequate skin spacing between balloon surface and surface of the skin (>7mm)

This is a partial list of eligibility requirements. To discuss your specific eligibility, call the number provided.